PPARγ signaling and emerging opportunities for improved therapeutics.
about
Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte DifferentiationRetinoic acid receptor-related orphan receptor α stimulates adipose tissue inflammation by modulating endoplasmic reticulum stress.Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.PPAR Agonists and Metabolic Syndrome: An Established Role?The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
P2860
PPARγ signaling and emerging opportunities for improved therapeutics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
PPARγ signaling and emerging opportunities for improved therapeutics.
@en
type
label
PPARγ signaling and emerging opportunities for improved therapeutics.
@en
prefLabel
PPARγ signaling and emerging opportunities for improved therapeutics.
@en
P2093
P2860
P1476
PPARγ signaling and emerging opportunities for improved therapeutics.
@en
P2093
Edward J Dougherty
Robert L Danner
Shuibang Wang
P2860
P356
10.1016/J.PHRS.2016.02.028
P577
2016-06-03T00:00:00Z